Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis
Brain diseases pose significant treatment challenges due to the restrictive nature of the blood–brain barrier (BBB). Recent advances in targeting macromolecules offer promising avenues for overcoming these obstacles through receptor-mediated transcytosis (RMT). We summarize the current progress in t...
Saved in:
Main Authors: | Yuanke Li, Ruiying Liu, Zhen Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/17/1/109 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reducing neonatal Fc receptor binding enhances clearance and brain-to-blood ratio of TfR-delivered bispecific amyloid-β antibody
by: Eva Schlein, et al.
Published: (2024-12-01) -
Transcytosis of T4 Bacteriophage Through Intestinal Cells Enhances Its Immune Activation
by: Amanda Carroll-Portillo, et al.
Published: (2025-01-01) -
Peptide Aptamer–Paclitaxel Conjugates for Tumor Targeted Therapy
by: Xinyang Shen, et al.
Published: (2024-12-01) -
CAVIN-2 positively correlates with diabetic PAD and promotes LDL transcytosis by inhibiting eNOS activation
by: Li Wang, et al.
Published: (2025-12-01) -
A minimal mathematical model for the initial molecular interactions of death receptor signalling
by: Christian Winkel, et al.
Published: (2012-06-01)